Clinical Trial Update: Low-Count Quantitative SPECT for Men Treated With Radium-223 [NA]

View source ↗

Summary

This clinical trial investigates low-count quantitative SPECT imaging in men treated with Radium-223 for prostate cancer. The study is currently not yet recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Xofigo (radium-223 dichloride)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Prostate Cancer, Cancer of the Prostate | NA | Status: NOT_YET_RECRUITING